<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM7959</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-7959</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Вопросы патогенеза</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Pathogenesis</subject></subj-group></article-categories><title-group><article-title>Резистентность к инсулину – конфликт между биологическими настройками энергетического метаболизма и образом жизни человека (взгляд на проблему с эволюционных позиций)</article-title><trans-title-group xml:lang="en"><trans-title>Insulin resistance: the conflict between biological settings of energy metabolism and human lifestyle (a glance at the problem from evolutionary viewpoint)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титов</surname><given-names>Владимир Николаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Titov</surname><given-names>Vladimir Nicolaevich</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">vn_titov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4643-5507</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ширинский</surname><given-names>Владимир Павлович</given-names></name><name name-style="western" xml:lang="en"><surname>Shirinsky</surname><given-names>Vladimir Pavlovich</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">shirinsky@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ Российский кардиологический научно-производственный комплекс Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research and Production Complex, Moscow, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ Российский кардиологический научно-производственный комплекс Минздрава России, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research and Production Complex, Moscow, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2016</year></pub-date><volume>19</volume><issue>4</issue><issue-title>Том 19, №4(2016)</issue-title><fpage>286</fpage><lpage>294</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Титов В.Н., Ширинский В.П., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Титов В.Н., Ширинский В.П.</copyright-holder><copyright-holder xml:lang="en">Titov V.N., Shirinsky V.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/7959">https://www.dia-endojournals.ru/jour/article/view/7959</self-uri><abstract><p>Биологическое предназначение позднего в филогенезе гуморального медиатора инсулина состоит в обеспечении субстратами для наработки энергии биологической функции локомоции, движения за счет сокращения поперечнополосатых миоцитов. Инсулин призван реализовать эволюционное развитие – повысить кинетические параметры организма за счет эффективной наработки АТФ митохондриями. Субстратами же для синтеза АТФ являются, в первую очередь, экзогенные жирные кислоты, оптимальные эндогенные жирные кислоты, синтезированные из экзогенной глюкозы, и сама глюкоза. При действии инсулина клетки из глюкозы синтезируют ω-9 С18:1 олеиновую жирную кислоту; митохондрии окисляют ее с более высокой скоростью, чем экзогенную и эндогенно синтезированную С16:0 пальмитиновую жирную кислоту. При физиологичном действии инсулина и нормальной функции митохондрий наиболее частой причиной формирования резистентности к инсулину являются неоптимальные свойства экзогенных жирных кислот пищи для окисления их в митохондриях.</p><p>Превышение в пище содержания пальмитиновой насыщенной жирной кислоты над олеиновой мононенасыщенной жирной кислотой – условие формирования синдрома резистентности к инсулину. Основа синдрома резистентности к инсулину – хроническое состояние дефицита in vivo энергии, недостаточная продукция АТФ для реализации биологической функции адаптации, биологической реакции компенсации. Поздний в филогенезе инсулин эффективно ингибирует липолиз только в филогенетически поздних подкожных адипоцитах, но не в более ранних в филогенезе висцеральных жировых клетках сальника. Несогласованность регуляции метаболизма субстратов энергии в разных депо жировых клеток in vivo на фоне кажущегося «относительного биологического совершенства» и составляет этиологическую основу резистентности к инсулину.</p></abstract><trans-abstract xml:lang="en"><p>A biological function of the phylogenetically late humoral mediator insulin is to provide energy substrates for locomotion, i.e. movement resulting from contraction of striated muscles. Insulin is able to meet this evolutionary demand of an organism by means of the effective ATP production in the mitochondria. Exogenous fatty acids, optimised endogenous fatty acids produced from glucose and glucose itself are the major substrates for ATP synthesis. Cells stimulated by insulin produce ω-9 С18:1 oleic acid from glucose. This fatty acid is oxidised by the mitochondria at a higher rate than exogenous and endogenous C16:0 palmitic fatty acid. In the normal state of insulin system and mitochondria, the frequent cause of insulin resistance is the non-optimal properties of dietary fatty acids supplied for oxidation by the mitochondria. Dietary excess of saturated palmitic fatty acid over monogenic oleic fatty acid causes insulin resistance to develop. Insulin resistance syndrome is the condition of in vivo energy deficiency and insufficient production of ATP for the realisation of the biological adaptation and compensation. Insulin effectively inhibits lipolysis only in phylogenetically late subcutaneous adipocytes but not in phylogenetically early visceral fat cells of the omentum. Discrepancy in the regulation of energy substrate metabolism against the background of a ‘relative biological perfection’ of higher mammals is the aetiological basis of insulin resistance.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инсулин</kwd><kwd>резистентность к инсулину</kwd><kwd>АТФ</kwd><kwd>пальмитиновая кислота</kwd><kwd>олеиновая кислота</kwd><kwd>биологическая адаптация</kwd><kwd>глюкоза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>insulin</kwd><kwd>insulin resistance</kwd><kwd>ATP</kwd><kwd>palmitic acid</kwd><kwd>oleic acid</kwd><kwd>biological adaptation</kwd><kwd>glucose</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Грант Российского научного фонда 14-35-00026.</funding-statement><funding-statement xml:lang="en">Grant by Russian Science Foundation (14-35-00026)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Титов В.Н. Филогенетическая теория общей патологии. Патогенез метаболических пандемий. Сахарный диабет. – М.: ИНФРА-М; 2014. [Titov VN. Filogeneticheskaya teoriya obshchei patologii. Patogenez metabolicheskikh pandemii. Sakharnyi diabet. Moscow: INFRA-M; 2014. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Титов В.Н. Филогенетическая теория общей патологии. Патогенез метаболических пандемий. Сахарный диабет. – М.: ИНФРА-М; 2014. [Titov VN. Filogeneticheskaya teoriya obshchei patologii. Patogenez metabolicheskikh pandemii. Sakharnyi diabet. Moscow: INFRA-M; 2014. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Шноль С.Э. Физико-химические факторы биологической эволюции. – М.: Наука; 1979. [Shnol’ SE. Fiziko-khimicheskie faktory biologicheskoi evolyutsii. Moscow: Nauka; 1979. (In Russ)]</mixed-citation><mixed-citation xml:lang="en">Шноль С.Э. Физико-химические факторы биологической эволюции. – М.: Наука; 1979. [Shnol’ SE. Fiziko-khimicheskie faktory biologicheskoi evolyutsii. Moscow: Nauka; 1979. (In Russ)]</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hamerly T, Tripet B, Wurch L, et al. Characterization of Fatty Acids in Crenarchaeota by GC-MS and NMR. Archaea. 2015;2015:472726. doi: 10.1155/2015/472726</mixed-citation><mixed-citation xml:lang="en">Hamerly T, Tripet B, Wurch L, et al. Characterization of Fatty Acids in Crenarchaeota by GC-MS and NMR. Archaea. 2015;2015:472726. doi: 10.1155/2015/472726</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147-152. doi: 10.1172/JCI22422</mixed-citation><mixed-citation xml:lang="en">Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147-152. doi: 10.1172/JCI22422</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Montanaro MA, Bernasconi AM, Gonzalez MS, et al. Effects of fenofibrate and insulin on the biosynthesis of unsaturated fatty acids in streptozotocin diabetic rats. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):369-378. doi: 10.1016/j.plefa.2005.06.004</mixed-citation><mixed-citation xml:lang="en">Montanaro MA, Bernasconi AM, Gonzalez MS, et al. Effects of fenofibrate and insulin on the biosynthesis of unsaturated fatty acids in streptozotocin diabetic rats. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):369-378. doi: 10.1016/j.plefa.2005.06.004</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitamins and hormones. 2002;65:167-194. doi: 10.1016/s0083-6729(02)65064-2</mixed-citation><mixed-citation xml:lang="en">Shimano H. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitamins and hormones. 2002;65:167-194. doi: 10.1016/s0083-6729(02)65064-2</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Waters KM, Ntambi JM. Insulin and dietary fructose induce stearoyl-CoA desaturase 1 gene expression of diabetic mice. J Biol Chem. 1994;269(44):27773-27777.</mixed-citation><mixed-citation xml:lang="en">Waters KM, Ntambi JM. Insulin and dietary fructose induce stearoyl-CoA desaturase 1 gene expression of diabetic mice. J Biol Chem. 1994;269(44):27773-27777.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">DeLany JP, Windhauser MM, Champagne CM, et al. Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr. 2000;72(4):905-911.</mixed-citation><mixed-citation xml:lang="en">DeLany JP, Windhauser MM, Champagne CM, et al. Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr. 2000;72(4):905-911.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jones PJ, Pencharz PB, Clandinin MT. Whole body oxidation of dietary fatty acids: implications for energy utilization. Am J Clin Nutr. 1985;42(5):769-777.</mixed-citation><mixed-citation xml:lang="en">Jones PJ, Pencharz PB, Clandinin MT. Whole body oxidation of dietary fatty acids: implications for energy utilization. Am J Clin Nutr. 1985;42(5):769-777.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Pinnick KE, Neville MJ, Fielding BA, et al. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes. 2012;61(6):1399-1403. doi: 10.2337/db11-1810</mixed-citation><mixed-citation xml:lang="en">Pinnick KE, Neville MJ, Fielding BA, et al. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes. 2012;61(6):1399-1403. doi: 10.2337/db11-1810</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Лисицын Д.М., Разумовский С.Д., Тишенин М.А., и др. Кинетические параметры окисления озоном индивидуальных жирных кислот. // Бюллетень экспериментальной биологии и медицины. – 2004. – Т. 138. – №11 – С. 517-519. [Lisitsyn D, Razumovskii S, Tishenin M, et al. Kinetic parameters of oxidation of individual fatty acids with ozone. Bulletin of Experimental Biology and Medicine. 2004;138(11):517-519. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Лисицын Д.М., Разумовский С.Д., Тишенин М.А., и др. Кинетические параметры окисления озоном индивидуальных жирных кислот. // Бюллетень экспериментальной биологии и медицины. – 2004. – Т. 138. – №11 – С. 517-519. [Lisitsyn D, Razumovskii S, Tishenin M, et al. Kinetic parameters of oxidation of individual fatty acids with ozone. Bulletin of Experimental Biology and Medicine. 2004;138(11):517-519. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Панков Ю.А. Адипогенная функция и другие биологические эффекты инсулина. // Биомедицинская химия. – 2016. – Т. 62. – №1 – С. 5-13. [Pankov Y. Adipogenic function and other biologic effects of insulin. Biomeditsinskaya Khimiya. 2016;62(1):5-13. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Панков Ю.А. Адипогенная функция и другие биологические эффекты инсулина. // Биомедицинская химия. – 2016. – Т. 62. – №1 – С. 5-13. [Pankov Y. Adipogenic function and other biologic effects of insulin. Biomeditsinskaya Khimiya. 2016;62(1):5-13. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand. 2005;183(1):13-30. doi: 10.1111/j.1365-201X.2004.01385.x</mixed-citation><mixed-citation xml:lang="en">Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand. 2005;183(1):13-30. doi: 10.1111/j.1365-201X.2004.01385.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Титов В.Н., Рожкова Т.А., Амелюшкина В.А. Жирные кислоты, триглицериды, гипертриглицеридемия, гипергликемия и инсулин. – М.: ИНФРА; 2016. [Titov VN, Rozhkova TA, Amelyushkina VA. Zhirnye kisloty, triglitseridy, gipertriglitseridemiya, giperglikemiya i insulin. Moscow: INFRA; 2016. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Титов В.Н., Рожкова Т.А., Амелюшкина В.А. Жирные кислоты, триглицериды, гипертриглицеридемия, гипергликемия и инсулин. – М.: ИНФРА; 2016. [Titov VN, Rozhkova TA, Amelyushkina VA. Zhirnye kisloty, triglitseridy, gipertriglitseridemiya, giperglikemiya i insulin. Moscow: INFRA; 2016. (In Russ).]</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Stamatikos AD, Paton CM. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism. Am J Physiol Endocrinol Metab. 2013;305(7):E767-775. doi: 10.1152/ajpendo.00268.2013</mixed-citation><mixed-citation xml:lang="en">Stamatikos AD, Paton CM. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism. Am J Physiol Endocrinol Metab. 2013;305(7):E767-775. doi: 10.1152/ajpendo.00268.2013</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr.2010;91(1):46-63. doi: 10.3945/ajcn.2009.27661</mixed-citation><mixed-citation xml:lang="en">Hunter JE, Zhang J, Kris-Etherton PM. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr.2010;91(1):46-63. doi: 10.3945/ajcn.2009.27661</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Brown JM, Rudel LL. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol. 2010;21(3):192-197. doi: 10.1097/MOL.0b013e32833854ac</mixed-citation><mixed-citation xml:lang="en">Brown JM, Rudel LL. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol. 2010;21(3):192-197. doi: 10.1097/MOL.0b013e32833854ac</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X, Miyazaki M, Flowers MT, et al. Loss of Stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate. Arterioscler Thromb Vasc Biol. 2010;30(1):31-38. doi: 10.1161/ATVBAHA.109.195636</mixed-citation><mixed-citation xml:lang="en">Liu X, Miyazaki M, Flowers MT, et al. Loss of Stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate. Arterioscler Thromb Vasc Biol. 2010;30(1):31-38. doi: 10.1161/ATVBAHA.109.195636</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ntambi JM, Miyazaki M, Dobrzyn A. Regulation of stearoyl-CoA desaturase expression. Lipids. 2004;39(11):1061-1065. doi: 10.1007/s11745-004-1331-2</mixed-citation><mixed-citation xml:lang="en">Ntambi JM, Miyazaki M, Dobrzyn A. Regulation of stearoyl-CoA desaturase expression. Lipids. 2004;39(11):1061-1065. doi: 10.1007/s11745-004-1331-2</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Dobrzyn A, Dobrzyn P. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation. J Physiol Pharmacol. 2006;57 Suppl 10:31-42.</mixed-citation><mixed-citation xml:lang="en">Dobrzyn A, Dobrzyn P. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation. J Physiol Pharmacol. 2006;57 Suppl 10:31-42.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Silbernagel G, Kovarova M, Cegan A, et al. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J Clin Endocrinol Metab. 2012;97(12):E2288-2292. doi: 10.1210/jc.2012-2152</mixed-citation><mixed-citation xml:lang="en">Silbernagel G, Kovarova M, Cegan A, et al. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J Clin Endocrinol Metab. 2012;97(12):E2288-2292. doi: 10.1210/jc.2012-2152</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Peter A, Cegan A, Wagner S, et al. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem.2009;55(12):2113-2120. doi: 10.1373/clinchem.2009.127274</mixed-citation><mixed-citation xml:lang="en">Peter A, Cegan A, Wagner S, et al. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem.2009;55(12):2113-2120. doi: 10.1373/clinchem.2009.127274</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Stefan N, Peter A, Cegan A, et al. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia. 2008;51(4):648-656. doi: 10.1007/s00125-008-0938-7</mixed-citation><mixed-citation xml:lang="en">Stefan N, Peter A, Cegan A, et al. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia. 2008;51(4):648-656. doi: 10.1007/s00125-008-0938-7</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YC, Gomez FE, Fox BG, et al. Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes. J Lipid Res. 2000;41(8):1310-1316.</mixed-citation><mixed-citation xml:lang="en">Kim YC, Gomez FE, Fox BG, et al. Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes. J Lipid Res. 2000;41(8):1310-1316.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Титов В.Н. Филогенетическая теория общей патологии. Патогенез болезней цивилизации. Атеросклероз. – М.: ИНФРА-М; 2014. [Titov VN. Filogeneticheskaya teoriya obshchei patologii.Patogenez boleznei tsivilizatsii. Ateroskleroz. Moscow: INFRA-M; 2014. (In Russ).]</mixed-citation><mixed-citation xml:lang="en">Титов В.Н. Филогенетическая теория общей патологии. Патогенез болезней цивилизации. Атеросклероз. – М.: ИНФРА-М; 2014. [Titov VN. Filogeneticheskaya teoriya obshchei patologii.Patogenez boleznei tsivilizatsii. Ateroskleroz. Moscow: INFRA-M; 2014. (In Russ).]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
